Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417846 · ClinicalTrials.gov registry record
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
A clinical trial of Choroidal Neovascularization and Maculopathy, Age-Related, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 98
- Enrollment target
- 4
- Study locations
NCT00417846 is a study of Choroidal Neovascularization and Maculopathy, Age-Related that has completed, run by Johns Hopkins University. The registered enrollment target is 98 participants, below the 172-participant average among 7 other Choroidal Neovascularization trials with a reported enrollment target (43% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00417846, a study of Choroidal Neovascularization and Maculopathy, Age-Related, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to determine the sensitivity of the optical coherence tomography (OCT) test in detecting neovascular AMD in eyes at high risk for CNV development. In order to test this hypothesis, we are conducting a multi-center clinical study at four participating clinical centers. A total of 227 participants will be enrolled. Participants will be followed-up for a period of two years, or until CNV develops in the study eye for which treatment is recommended, to determine the occurrence of CNV. The fundamental design principles of the study are simplicity and parsimony.
Conditions Studied
Study Locations (4)
California
- Retina Vitreous Associates - Beverly Hills
Maryland
- The Wilmer Eye Institute at Johns Hopkins - Baltimore
Massachusetts
- Ophthalmic Consultants of Boston - Boston
Ohio
- Retina Associates of Cleveland - Beachwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00417846
The ClinicalTrials.gov registry entry for NCT00417846 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 7 other Choroidal Neovascularization trials with a reported enrollment target (43% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Choroidal Neovascularization appearing as the primary indexed condition, and to 0 interventions.
NCT00417846 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00417846 about?
NCT00417846 is a clinical study titled "Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)". The purpose of this study is to determine the sensitivity of the optical coherence tomography (OCT) test in detecting neovascular AMD in eyes at high risk for CNV development. In order to test this hypothesis, we are conducting a multi-center clinical study at four participating clinical centers. A ...
What is the current status of trial NCT00417846?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2007-01. Estimated completion is 2009-08.
What conditions does trial NCT00417846 study?
This clinical trial studies the following conditions: Choroidal Neovascularization, Maculopathy, Age-Related.
Who is sponsoring clinical trial NCT00417846?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00417846 being conducted?
This trial has 4 study locations across California, Maryland, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Choroidal Neovascularization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
RECRUITING · Phase 2
-
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
COMPLETED
-
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
COMPLETED · Phase 2
-
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
COMPLETED · NA
-
Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
COMPLETED · Phase 1
-
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.